P2X7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus
- 16 October 2008
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 72 (5) , 487-490
Abstract
The P2X7 receptor is a ligand‐gated cation‐selective channel that mediates ATP‐induced apoptosis of cells of the immune system. A loss‐of‐function single nucleotide polymorphism (SNP) at position 1513 (1513 A→C) of the P2X7 gene has recently been identified in both healthy and chronic lymphocytic leukemia (CLL) B‐cells, translating into a loss of P2X7‐mediated apoptosis in these cells. This antiapoptotic effect results in increased B‐cell numbers, thereby potentially contributing to the survival of B‐CLL clones. It was hypothesized that prolonged cell survival may also predispose to induction of autoimmunity. The objective of this study is to analyze the role of the P2X7 receptor and its loss‐of‐function 1513 A→C polymorphism (SNP) in the development of systemic lupus erythematosus (SLE). DNA samples obtained from patients with sporadic SLE were analyzed for the presence of the 1513 A→C polymorphism using polymerase chain reaction (PCR) amplification and then direct sequencing. No significant difference in allele frequencies (1513 A→C polymorphism) between sporadic cases of SLE and controls was found. A loss‐of‐function SNP at position 1513 (1513 A→C) of the P2X7 gene does not appear to be a susceptibility gene locus for the development of sporadic SLE.Keywords
This publication has 32 references indexed in Scilit:
- An Arg307 to Gln Polymorphism within the ATP-binding Site Causes Loss of Function of the Human P2X7 ReceptorJournal of Biological Chemistry, 2004
- 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcomeEuropean Journal of Haematology, 2004
- Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosusArthritis & Rheumatism, 2003
- The P2X7 receptor gene polymorphism 1513 A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl‐2 family protein expression or survival in B‐cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 2003
- P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12Leukemia, 2003
- A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 ReceptorJournal of Biological Chemistry, 2001
- Circulating P- and L-Selectin and T-Lymphocyte Activation in Patients with Autoimmune Rheumatic DiseasesClinical Rheumatology, 1999
- Role of the Purinergic P2Z Receptor in Spontaneous Cell Death in J774 Macrophage CulturesBiochemical and Biophysical Research Communications, 1996
- Lupus: Key Pathogenic Mechanisms and Contributing FactorsClinical Immunology and Immunopathology, 1995
- The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role.Journal of Clinical Investigation, 1995